Your browser is no longer supported. Please, upgrade your browser.
Settings
ILMN [NASD]
Illumina, Inc.
IndexS&P 500 P/E90.03 EPS (ttm)4.43 Insider Own0.30% Shs Outstand147.00M Perf Week-1.08%
Market Cap58.65B Forward P/E57.64 EPS next Y6.92 Insider Trans-14.81% Shs Float145.63M Perf Month-5.03%
Income656.00M PEG4.19 EPS next Q1.39 Inst Own93.90% Short Float2.15% Perf Quarter7.54%
Sales3.24B P/S18.11 EPS this Y-34.10% Inst Trans0.34% Short Ratio2.61 Perf Half Y20.87%
Book/sh31.93 P/B12.50 EPS next Y25.56% ROA8.90% Target Price404.31 Perf Year31.47%
Cash/sh23.62 P/C16.89 EPS next 5Y21.50% ROE14.10% 52W Range260.42 - 555.77 Perf YTD7.84%
Dividend- P/FCF65.82 EPS past 5Y7.40% ROI6.50% 52W High-27.28% Beta0.95
Dividend %- Quick Ratio3.30 Sales past 5Y7.90% Gross Margin68.00% 52W Low55.18% ATR15.12
Employees7800 Current Ratio3.60 Sales Q/Q0.10% Oper. Margin17.90% RSI (14)49.62 Volatility2.49% 3.50%
OptionableYes Debt/Eq0.25 EPS Q/Q8.30% Profit Margin20.30% Rel Volume0.52 Prev Close399.00
ShortableYes LT Debt/Eq0.14 EarningsApr 27 AMC Payout0.00% Avg Volume1.20M Price404.13
Recom2.70 SMA200.91% SMA50-4.65% SMA2009.81% Volume468,885 Change1.29%
Mar-31-21Upgrade Canaccord Genuity Hold → Buy $445
Mar-31-21Downgrade Atlantic Equities Overweight → Neutral $390
Mar-03-21Initiated Barclays Underweight $325
Dec-22-20Upgrade Piper Sandler Neutral → Overweight $340 → $415
Dec-17-20Upgrade BTIG Research Neutral → Buy $410
Oct-13-20Downgrade Guggenheim Buy → Neutral
Sep-30-20Initiated Atlantic Equities Overweight $355
Sep-29-20Downgrade Wolfe Research Outperform → Peer Perform
Sep-22-20Downgrade UBS Buy → Neutral $390 → $285
Sep-22-20Downgrade Stifel Buy → Hold $380 → $280
Sep-21-20Upgrade Guggenheim Neutral → Buy $345
Sep-21-20Downgrade JP Morgan Overweight → Neutral $390 → $280
Sep-09-20Initiated Morgan Stanley Equal-Weight $400
Aug-07-20Downgrade Piper Sandler Overweight → Neutral $356 → $340
Aug-07-20Downgrade Evercore ISI In-line → Underperform $310
Jul-07-20Downgrade Guggenheim Buy → Neutral
Apr-24-20Downgrade Citigroup Buy → Neutral $250 → $320
Apr-21-20Downgrade Robert W. Baird Outperform → Neutral $310
Jan-08-20Initiated Wells Fargo Underweight $300
Jan-07-20Initiated Citigroup Buy $385
Apr-17-21 06:42AM  
Apr-15-21 08:54AM  
Apr-14-21 04:24PM  
07:01AM  
Apr-12-21 08:00PM  
12:10PM  
07:26AM  
Apr-09-21 06:32AM  
06:04AM  
Apr-08-21 03:19PM  
03:16PM  
Apr-07-21 11:40AM  
09:36AM  
08:00AM  
Apr-06-21 04:32PM  
03:56PM  
02:00PM  
12:39PM  
12:17PM  
11:40AM  
11:05AM  
10:37AM  
09:56AM  
08:04AM  
06:46AM  
04:36AM  
03:30AM  
Apr-05-21 04:46PM  
04:30PM  
08:55AM  
Apr-01-21 08:06AM  
Mar-31-21 08:58AM  
06:12AM  
Mar-30-21 09:12PM  
08:00PM  
04:41PM  
03:34PM  
03:17PM  
01:04PM  
Mar-29-21 08:00PM  
10:01AM  
Mar-28-21 06:04AM  
Mar-25-21 06:45AM  
Mar-23-21 04:03AM  
Mar-18-21 04:05PM  
10:14AM  
Mar-16-21 10:11AM  
07:30AM  
Mar-14-21 06:45AM  
Mar-12-21 08:35AM  
Mar-11-21 04:05PM  
06:54AM  
Mar-10-21 04:15PM  
Mar-08-21 08:10PM  
09:30AM  
Mar-07-21 06:45AM  
Mar-05-21 05:50PM  
01:00AM  
Mar-02-21 07:05AM  
Feb-22-21 07:00PM  
Feb-19-21 12:29PM  
01:00AM  
Feb-16-21 12:48PM  
Feb-15-21 02:58AM  
Feb-12-21 04:21PM  
02:52PM  
12:00PM  
10:27AM  
09:17AM  
07:56AM  
07:36AM  
Feb-11-21 10:31PM  
05:35PM  
04:56PM  
04:20PM  
04:05PM  
03:15PM  
Feb-10-21 10:47AM  
07:00AM  
05:20AM  
Feb-08-21 01:35PM  
09:15AM  
09:05AM  
08:42AM  
Feb-04-21 05:00AM  
Feb-02-21 06:12AM  
Feb-01-21 09:36AM  
06:08AM  
Jan-31-21 07:00PM  
Jan-27-21 06:10AM  
Jan-25-21 10:00AM  
08:21AM  
04:20AM  
Jan-22-21 07:57AM  
01:02AM  
Jan-20-21 04:05PM  
Jan-15-21 02:16PM  
Jan-14-21 08:29AM  
Jan-13-21 08:09AM  
Jan-12-21 08:40AM  
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FLATLEY JAY TDirectorApr 06Sale423.444,0001,693,740160,933Apr 07 04:41 PM
TOUSI SUSAN HSVP Product DevelopmentApr 06Sale423.44500211,71844,143Apr 07 04:34 PM
TOUSI SUSAN HSVP Product DevelopmentApr 05Sale386.03300115,80944,643Apr 07 04:34 PM
Dadswell CharlesSVP & General CounselMar 22Sale416.24314130,6996,832Mar 24 04:41 PM
FLATLEY JAY TDirectorMar 16Sale421.064,0001,684,240164,933Mar 18 07:20 PM
TOUSI SUSAN HSVP Product DevelopmentMar 05Sale402.24800321,79244,943Mar 09 05:29 PM
FLATLEY JAY TDirectorMar 02Sale444.614,0001,778,440168,933Mar 04 05:04 PM
MCGINNIS KAREN KVP, Chief Accounting OfficerFeb 18Sale486.75666324,1761,538Feb 22 05:11 PM
TOUSI SUSAN HSVP Product DevelopmentFeb 17Option Exercise0.006,306048,921Feb 18 04:52 PM
SAMAD SAMSVP and CFOFeb 17Option Exercise0.004,37909,355Feb 18 04:51 PM
RAGUSA ROBERT PSVP, Global Quality & OpsFeb 17Option Exercise0.006,306012,795Feb 18 04:49 PM
MCGINNIS KAREN KVP, Chief Accounting OfficerFeb 17Option Exercise0.0093502,576Feb 18 04:47 PM
Hoyt Aimee LSVP, Chief People OfficerFeb 17Option Exercise0.004,62508,873Feb 18 04:45 PM
Febbo Phillip G.SVP Chief Medical OfficerFeb 17Option Exercise0.003,17307,046Feb 18 04:44 PM
deSouza Francis APresident and CEOFeb 17Option Exercise0.0024,521085,934Feb 18 04:42 PM
Dadswell CharlesSVP & General CounselFeb 17Option Exercise0.003,50308,781Feb 18 04:41 PM
FLATLEY JAY TDirectorFeb 16Sale495.09500247,5433,500Feb 18 07:08 PM
FLATLEY JAY TDirectorFeb 16Sale505.264,0002,021,040172,933Feb 18 07:08 PM
TOUSI SUSAN HSVP Product DevelopmentFeb 05Sale431.90800345,52039,713Feb 09 04:48 PM
Hoyt Aimee LSVP, Chief People OfficerFeb 02Sale444.845725,3562,359Feb 03 05:00 PM
FLATLEY JAY TDirectorFeb 02Sale444.844,0001,779,360176,933Feb 03 04:58 PM
MCGINNIS KAREN KVP, Chief Accounting OfficerFeb 02Sale444.847232,0281,538Feb 03 04:57 PM
deSouza Francis APresident and CEOFeb 01Sale439.783,0001,319,33052,603Feb 03 04:56 PM
TOUSI SUSAN HSVP Product DevelopmentJan 20Sale400.002,5001,000,00040,447Jan 21 04:40 PM
FLATLEY JAY TDirectorJan 19Sale382.484,0001,529,920180,933Jan 21 04:38 PM
Hoyt Aimee LSVP, Chief People OfficerJan 11Sale379.65271102,8852,359Jan 12 04:41 PM
TOUSI SUSAN HSVP Product DevelopmentJan 05Sale365.27300109,58142,947Jan 06 07:20 PM
FLATLEY JAY TDirectorJan 05Sale365.274,0001,461,080184,933Jan 06 07:19 PM
deSouza Francis APresident and CEOJan 04Sale370.513,0001,111,53755,540Jan 06 07:17 PM
FLATLEY JAY TDirectorDec 15Sale348.844,0001,395,360188,933Dec 16 06:07 PM
Hoyt Aimee LSVP, Chief People OfficerDec 14Sale345.00354122,1302,744Dec 16 06:05 PM
Ronaghi MostafaSVP, Entrepreneurial DevlopmtDec 10Sale338.585,0001,692,92280,162Dec 14 04:12 PM
TOUSI SUSAN HSVP Product DevelopmentDec 07Sale349.34300104,80343,247Dec 08 05:34 PM
TOUSI SUSAN HSVP Product DevelopmentDec 04Sale350.0020070,00043,547Dec 08 05:34 PM
Dadswell CharlesSVP & General CounselDec 01Sale323.861,694548,6193,460Dec 02 05:48 PM
deSouza Francis APresident and CEODec 01Sale327.953,000983,85158,540Dec 02 05:45 PM
TOUSI SUSAN HSVP Product DevelopmentDec 01Sale325.0010032,50043,747Dec 02 05:41 PM
FLATLEY JAY TDirectorDec 01Sale323.904,0001,295,590192,933Dec 02 05:37 PM
RAGUSA ROBERT PSVP, Global Quality & OpsNov 30Sale314.822,890909,8274,092Dec 02 05:34 PM
MCGINNIS KAREN KVP, Chief Accounting OfficerNov 18Sale300.0021865,4001,538Nov 19 04:16 PM
FLATLEY JAY TDirectorNov 17Sale297.163,000891,470196,933Nov 19 04:18 PM
MCGINNIS KAREN KVP, Chief Accounting OfficerNov 06Sale310.1031296,7511,872Nov 09 05:40 PM
Hoyt Aimee LSVP, Chief People OfficerNov 06Sale310.1021566,6723,098Nov 09 05:39 PM
Febbo Phillip G.SVP Chief Medical OfficerNov 06Sale310.1015548,0662,143Nov 09 05:35 PM
FLATLEY JAY TDirectorNov 03Sale297.343,000892,010199,933Nov 04 04:43 PM
deSouza Francis APresident and CEONov 02Sale300.283,000900,85265,840Nov 04 04:39 PM
Dadswell CharlesSVP & General CounselNov 02Sale298.0012136,0586,036Nov 04 04:34 PM
FLATLEY JAY TDirectorOct 20Sale321.714,0001,286,860202,933Oct 22 03:47 PM
TOUSI SUSAN HSVP Product DevelopmentOct 12Sale350.0020070,00044,968Oct 14 04:07 PM
TOUSI SUSAN HSVP Product DevelopmentOct 07Sale325.0010032,50045,168Oct 08 05:21 PM
FLATLEY JAY TDirectorOct 07Sale324.011,000324,010206,933Oct 08 05:18 PM
FLATLEY JAY TDirectorOct 06Sale317.793,000953,370207,933Oct 07 04:49 PM
deSouza Francis APresident and CEOOct 01Sale308.783,000926,33168,840Oct 05 05:14 PM
Dadswell CharlesSVP & General CounselOct 01Sale312.8212137,8516,157Oct 05 05:11 PM
FLATLEY JAY TDirectorSep 15Sale355.224,0001,420,880210,933Sep 17 04:59 PM
TOUSI SUSAN HSVP Product DevelopmentSep 09Sale350.0020070,00045,268Sep 10 04:49 PM
TOUSI SUSAN HSVP Product DevelopmentSep 08Sale336.0010033,60045,468Sep 10 04:49 PM
Van Oene MarkSVP Chief Commercial OfficerSep 01Sale355.13625221,95317,648Sep 02 07:52 PM
deSouza Francis APresident and CEOSep 01Sale352.323,0001,056,96471,840Sep 02 07:49 PM
Dadswell CharlesSVP & General CounselSep 01Sale355.351,687599,4756,278Sep 02 07:45 PM
FLATLEY JAY TDirectorSep 01Sale355.354,0001,421,400214,933Sep 02 07:35 PM
RAGUSA ROBERT PSVP, Global Quality & OpsAug 31Sale355.185,0001,775,9078,103Sep 02 07:29 PM
FLATLEY JAY TDirectorAug 18Sale354.034,0001,416,120218,933Aug 20 05:14 PM
MCGINNIS KAREN KVP, Chief Accounting OfficerAug 10Sale357.011,856662,6112,350Aug 12 04:32 PM
TOUSI SUSAN HSVP Product DevelopmentAug 05Sale399.02800319,22045,568Aug 06 04:21 PM
Hoyt Aimee LSVP, Chief People OfficerAug 04Sale397.732911,5343,498Aug 05 05:57 PM
FLATLEY JAY TDirectorAug 04Sale397.734,0001,590,920222,933Aug 05 05:54 PM
Van Oene MarkSVP Chief Commercial OfficerAug 03Sale385.43625240,89418,255Aug 05 05:50 PM
Dadswell CharlesSVP & General CounselAug 03Sale385.1912146,6087,913Aug 05 05:41 PM
deSouza Francis APresident and CEOAug 03Sale389.853,0001,169,54374,822Aug 05 04:57 PM
FLATLEY JAY TDirectorJul 21Sale399.004,0001,596,000226,933Jul 22 04:46 PM
TOUSI SUSAN HSVP Product DevelopmentJul 20Sale400.00500200,00046,354Jul 22 04:49 PM
FLATLEY JAY TDirectorJul 07Sale370.224,0001,480,880230,933Jul 08 04:52 PM
TOUSI SUSAN HSVP Product DevelopmentJul 06Sale375.00300112,50046,854Jul 08 04:40 PM
Van Oene MarkSVP Chief Commercial OfficerJul 01Sale369.40625230,87418,880Jul 06 04:25 PM
deSouza Francis APresident and CEOJul 01Sale366.653,0001,099,96078,158Jul 06 04:13 PM
Dadswell CharlesSVP & General CounselJul 01Sale369.2612144,6808,034Jul 06 04:07 PM
FLATLEY JAY TDirectorJun 16Sale354.934,0001,419,720234,933Jun 17 04:18 PM
RAGUSA ROBERT PSVP, Global Quality & OpsJun 15Sale340.765,0001,703,80913,056Jun 17 04:15 PM
Hoyt Aimee LSVP, Chief People OfficerJun 08Sale350.9419167,0303,498Jun 10 05:09 PM
FLATLEY JAY TDirectorJun 02Sale364.404,0001,457,600238,933Jun 03 04:37 PM
deSouza Francis APresident and CEOJun 01Sale362.783,0001,088,32981,158Jun 03 04:34 PM
Van Oene MarkSVP Chief Commercial OfficerJun 01Sale361.54625225,96219,505Jun 03 04:27 PM
Dadswell CharlesSVP & General CounselJun 01Sale362.601,686611,3448,155Jun 03 04:25 PM
TOUSI SUSAN HSVP Product DevelopmentMay 28Sale375.00600225,00047,154Jun 01 04:34 PM
SAMAD SAMSVP and CFOMay 26Sale360.001,356488,1603,879May 28 06:20 PM
TOUSI SUSAN HSVP Product DevelopmentMay 20Sale350.00300105,00047,754May 21 04:51 PM
FLATLEY JAY TDirectorMay 19Sale342.344,0001,369,360241,970May 20 06:48 PM
SAMAD SAMSVP and CFOMay 18Sale340.001,357461,3805,235May 20 06:50 PM
TOUSI SUSAN HSVP Product DevelopmentMay 12Sale325.00600195,00048,054May 13 06:08 PM
OSTADAN OMEADSVP Mktg, Prod & Strat PlanMay 11Sale315.132,140674,36917,172May 13 06:04 PM
ARNOLD FRANCESDirectorMay 11Sale309.111,503464,5929,954May 13 05:57 PM
FLATLEY JAY TDirectorMay 05Sale310.373,000931,110245,970May 07 05:57 PM
Van Oene MarkSVP Chief Commercial OfficerMay 01Sale316.83625198,01620,130May 05 07:01 PM
deSouza Francis APresident and CEOMay 01Sale308.613,000925,81984,158May 05 06:35 PM
Dadswell CharlesSVP & General CounselMay 01Sale317.1612138,3769,841May 05 06:22 PM
FLATLEY JAY TDirectorApr 21Sale310.773,000932,310248,970Apr 22 04:52 PM
SAMAD SAMSVP and CFOApr 20Sale320.021,356433,9476,592Apr 22 04:54 PM